- Home
- KYMR vs ROOT Comparison
KYMR vs ROOT Comparison
Compare KYMR & ROOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- ROOT
- Stock Information
- Founded
- KYMR 2015
- ROOT 2015
- Country
- KYMR United States
- ROOT United States
- Employees
- KYMR N/A
- ROOT N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- ROOT Property-Casualty Insurers
- Sector
- KYMR Health Care
- ROOT Finance
- Exchange
- KYMR Nasdaq
- ROOT Nasdaq
- Market Cap
- KYMR 1.8B
- ROOT 1.7B
- IPO Year
- KYMR 2020
- ROOT 2020
- Fundamental
- Price
- KYMR $30.53
- ROOT $148.46
- Analyst Decision
- KYMR Buy
- ROOT Buy
- Analyst Count
- KYMR 13
- ROOT 7
- Target Price
- KYMR $56.69
- ROOT $120.83
- AVG Volume (30 Days)
- KYMR 762.3K
- ROOT 531.8K
- Earning Date
- KYMR 05-09-2025
- ROOT 05-07-2025
- Dividend Yield
- KYMR N/A
- ROOT N/A
- EPS Growth
- KYMR N/A
- ROOT N/A
- EPS
- KYMR N/A
- ROOT 3.16
- Revenue
- KYMR $47,072,000.00
- ROOT $1,271,000,000.00
- Revenue This Year
- KYMR $16.24
- ROOT $12.28
- Revenue Next Year
- KYMR $22.41
- ROOT $12.34
- P/E Ratio
- KYMR N/A
- ROOT $44.77
- Revenue Growth
- KYMR N/A
- ROOT 98.66
- 52 Week Low
- KYMR $19.45
- ROOT $34.04
- 52 Week High
- KYMR $53.27
- ROOT $181.14
- Technical
- Relative Strength Index (RSI)
- KYMR 53.88
- ROOT 54.89
- Support Level
- KYMR $28.28
- ROOT $125.00
- Resistance Level
- KYMR $35.98
- ROOT $157.75
- Average True Range (ATR)
- KYMR 2.14
- ROOT 10.61
- MACD
- KYMR 0.01
- ROOT 0.06
- Stochastic Oscillator
- KYMR 50.71
- ROOT 62.91
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About ROOT Root Inc.
Root Inc develops and launches a direct-to-consumer personal automobile insurance and mobile technology company. The company is a direct-to-consumer personal auto insurance, renters insurance and mobile technology company. It generates revenue from the sales of auto insurance policies within the United States.